Ambrx Biopharma Inc. Profile Avatar - Palmy Investing

Ambrx Biopharma Inc.

Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (A…

Biotechnology
US, La Jolla [HQ]

News

Theses · Events · Sentiments
End of AMAM's Analysis
CIK: 1836056 CUSIP: 02290A102 ISIN: US6418711080 LEI: - UEI: -
Secondary Listings
AMAM has no secondary listings inside our databases.